Russia has registered the world’s first vaccine, Carnivac-Cov, against coronavirus for animals, the country’s media outlet TASS reported Wednesday.
World’s first coronavirus vaccine for animals approved by Russia
“Carnivac-Cov, a sorbate inactivated vaccine against the coronavirus infection for carnivorous animals, developed by Rosselkhoznadzor’s Federal Center for Animal Health, has been registered in Russia. So far, it is the world’s first and only product for preventing Covid-19 in animals,” Savenkov, the deputy head of Russia’s Federal Service for Veterinary and Phytosanitary Surveillance said Wednesday.
Russia already has introduced three coronavirus vaccines for humans, among which Sputnik V is the most popular. It was named after Sputnik, the world’s first satellite which the Soviet Union launched.
Clinical trials of Carnivac-Voc
According to Savenkov, the clinical trials of Carnivac-Cov initiated last October and involved dogs, cats, Arctic foxes, minks, foxes and other animals.
He also said all the vaccinated animals produced antibodies and the results of the research gave Russia grounds to conclude that the vaccine is safe and has strong immunogenic effect. The report mentioned that the effect of the vaccine is estimated to last no less than six months.
According to Russian scientists, the vaccine usage can help reduce further mutations of the virus. The Russian official continued that multiple firms from Greece, Poland and Austria have shown interest to buy the vaccine. Companies from the US, Canada and Singapore have also demonstrated interest as quoted by Savenkov.
Military officials in Saint Petersburg announced earlier this week that army dogs would receive compulsory vaccination before their deployment at airports and involvement in countrywide World War II commemorations in May.
In May 2020, Denmark picked out 17 million minks amid concerns the animals were carrying a mutated form of coronavirus. Moreover, the World Health Organization’s new report has also revealed Covid-19 might transfer to people through an animal.
Last year, Russia was the first country in the world to allow a coronavirus vaccine in humans. However, its early release before Phase 3 trials had ended was denounced worldwide.
Interim analysis of the Sputnik V coronavirus vaccine rolled out in February. It suggested 91.6% efficiency against symptomatic coronavirus and 100% effective against serious or normal disease.